We are live on ! Find out more
TNA

True North Advisors Portfolio holdings

AUM $1.05B
1-Year Est. Return 22.99%
This Fund
S&P 500
This Quarter Est. Return
+6.75%
1 Year Est. Return
+22.99%
3 Year Est. Return
+86.85%
5 Year Est. Return
+121.39%
10 Year Est. Return
AUM
$630M
AUM Growth
+$108M
Cap. Flow
+$87.1M
Cap. Flow %
13.83%
Top 10 Hldgs %
56.45%
Holding
258
New
36
Increased
123
Reduced
42
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 26.71%
2 Industrials 19.51%
3 Miscellaneous 13.85%
4 Financials 13.03%
5 Consumer Discretionary 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
126
HCA Healthcare
HCA
$90.5B
$533K 0.08%
1,250
+175
+16% +$67.8K
GEHC icon
127
GE HealthCare
GEHC
$32.4B
$525K 0.08%
6,987
+139
+2% +$10.4K
NOW icon
128
ServiceNow
NOW
$150B
$524K 0.08%
2,845
+580
+26% +$108K
VZ icon
129
Verizon
VZ
$208B
$506K 0.08%
+11,502
New +$498K
CL icon
130
Colgate-Palmolive
CL
$72.3B
$494K 0.08%
6,176
-629
-9% -$53.7K
PANW icon
131
Palo Alto Networks
PANW
$303B
$491K 0.08%
2,411
-960
-28% -$184K
AFL icon
132
Aflac
AFL
$58.4B
$487K 0.08%
4,364
+313
+8% +$32.9K
TSM icon
133
TSMC
TSM
$2.17T
$482K 0.08%
1,727
-124
-7% -$30.3K
GS icon
134
Goldman Sachs
GS
$301B
$482K 0.08%
605
+285
+89% +$211K
DIS icon
135
Walt Disney
DIS
$187B
$481K 0.08%
4,205
+870
+26% +$102K
GSLC icon
136
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$471K 0.07%
3,612
YDESW
137
YD Bio Ltd Warrants
YDESW
$4.8M
$467K 0.07%
+219,020
New +$382K
AMGN icon
138
Amgen
AMGN
$234B
$464K 0.07%
1,644
+639
+64% +$185K
TMO icon
139
Thermo Fisher Scientific
TMO
$230B
$458K 0.07%
944
+418
+79% +$195K
DVN icon
140
Devon Energy
DVN
$52.1B
$453K 0.07%
+12,921
New +$440K
IWP icon
141
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$453K 0.07%
3,180
HBAN icon
142
Huntington Bancshares
HBAN
$34.2B
$452K 0.07%
26,167
+206
+0.8% +$3.52K
ETR icon
143
Entergy
ETR
$49.3B
$448K 0.07%
4,809
+196
+4% +$17.2K
QUS icon
144
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.58B
$444K 0.07%
2,593
AZN icon
145
AstraZeneca
AZN
$252B
$439K 0.07%
2,862
+247
+9% +$37.4K
MPLX icon
146
MPLX
MPLX
$60.1B
$419K 0.07%
8,382
+35
+0.4% +$1.77K
INTU icon
147
Intuit
INTU
$97.9B
$408K 0.06%
597
+105
+21% +$75.7K
TGT icon
148
Target
TGT
$74.1B
$401K 0.06%
4,467
+817
+22% +$80.4K
GLD icon
149
SPDR Gold Trust
GLD
$149B
$400K 0.06%
+1,125
New +$359K
MMM icon
150
3M
MMM
$89.9B
$394K 0.06%
2,540
+418
+20% +$64.4K

Similar funds

True North Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, True North Advisors held 258 positions worth $630M, up 21% from $522M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

True North Advisors deployed $87.1M of net new capital in Q3 2025, opening 36 new positions and adding to 123 existing holdings. Its largest new stake was Avantis International Small Cap Value ETF: 87,812 shares worth $7.82M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 15% a quarter earlier, followed by Industrials and Miscellaneous.

On the sell side, the largest reduction was Lennox International, an estimated $2.25M trimmed.

  • True North Advisors's largest Q3 2025 buy was Avantis International Small Cap Value ETF: 87,812 shares worth $7.82M.
  • True North Advisors added most to Apple in Q3 2025, an estimated $43.7M increase.
  • True North Advisors's biggest Q3 2025 reduction was Lennox International, cutting an estimated $2.25M.
  • True North Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q3 2025, selling an estimated $15.9M.
  • True North Advisors's ten largest holdings make up 56% of its $630M portfolio in Q3 2025.
  • True North Advisors opened 36 new positions and closed 43 in Q3 2025.
  • True North Advisors's portfolio value rose 21% quarter-over-quarter to $630M.

Based on True North Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.